SHMT2 and non-small cell lung carcinoma: These data indicate that RT results in an elevated dependency on SHMT2 activity and consequently, ser/gly synthesis and downstream metabolic products, with the usage of these metabolites to sustain NSCLC proliferation and RT recovery.